Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dana C Andersen

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Current Opinion in Biotechnology|April 13, 2002
Recombinant protein expression for therapeutic applicationsDana C Andersen, Lynne Krummen
Current Opinion in Biotechnology|October 7, 2004
Production technologies for monoclonal antibodies and their fragmentsDana C Andersen, Dorothea E Reilly
Biotechnology and Bioengineering|March 18, 2005
Evaluation of different primary recovery methods for E. coli-derived recombinant human growth hormone and compatibility with further down-stream purificationJosefine Persson, Dana C Andersen, Philip M Lester
Biotechnology and Bioengineering|April 28, 2007
Proteome analysis of antibody-producing CHO cell lines with different metabolic profilesDeborah E Pascoe, David Arnott, Eleftherios T Papoutsakis, et al.
Biotechnology and Bioengineering|February 14, 2009
Plasmid-encoded protein: the principal factor in the "metabolic burden" associated with recombinant bacteria. Biotechnology Bioengineering, 1990William E Bentley, Noushin Mirjalili, Dana C Andersen, et al.
Biotechnology and Bioengineering|February 5, 2004
High-level accumulation of a recombinant antibody fragment in the periplasm of Escherichia coli requires a triple-mutant (degP prc spr) host strainChristina Chen, Brad Snedecor, Julie C Nishihara, et al.
Biotechnology and Bioengineering|May 28, 2011
Controlling glycation of recombinant antibody in fed-batch cell culturesInn H Yuk, Boyan Zhang, Yi Yang, et al.
Biotechnology Progress|April 4, 2017
A strategy to accelerate protein production from a pool of clones in Chinese hamster ovary cells for toxicology studiesZhilan Hu, Wendy Hsu, Abby Pynn, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Current Opinion in Biotechnology|April 13, 2002
Recombinant protein expression for therapeutic applicationsDana C Andersen, Lynne Krummen
Current Opinion in Biotechnology|October 7, 2004
Production technologies for monoclonal antibodies and their fragmentsDana C Andersen, Dorothea E Reilly
Biotechnology and Bioengineering|March 18, 2005
Evaluation of different primary recovery methods for E. coli-derived recombinant human growth hormone and compatibility with further down-stream purificationJosefine Persson, Dana C Andersen, Philip M Lester
Biotechnology and Bioengineering|April 28, 2007
Proteome analysis of antibody-producing CHO cell lines with different metabolic profilesDeborah E Pascoe, David Arnott, Eleftherios T Papoutsakis, et al.
Biotechnology and Bioengineering|February 14, 2009
Plasmid-encoded protein: the principal factor in the "metabolic burden" associated with recombinant bacteria. Biotechnology Bioengineering, 1990William E Bentley, Noushin Mirjalili, Dana C Andersen, et al.
Biotechnology and Bioengineering|February 5, 2004
High-level accumulation of a recombinant antibody fragment in the periplasm of Escherichia coli requires a triple-mutant (degP prc spr) host strainChristina Chen, Brad Snedecor, Julie C Nishihara, et al.
Biotechnology and Bioengineering|May 28, 2011
Controlling glycation of recombinant antibody in fed-batch cell culturesInn H Yuk, Boyan Zhang, Yi Yang, et al.
Biotechnology Progress|April 4, 2017
A strategy to accelerate protein production from a pool of clones in Chinese hamster ovary cells for toxicology studiesZhilan Hu, Wendy Hsu, Abby Pynn, et al.
Pageof 1